MRT
Marti Technologies, Inc.
There isn't enough reported data to score MRT yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
MRT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MRT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MRT PE Valuation
MRT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 154x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
MRT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
MRT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
MRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.01 | — |
| Q3 2026 | -$0.37 | +$0.47 |
| Q4 2025 | -$0.52 | +$0.76 |
| Q3 2025 | -$0.84 | +$0.15 |
| Q2 2025 | -$1.16 | -$0.72 |
| Q1 2025 | -$1.22 | -$0.78 |
| Q4 2024 | -$1.28 | -$0.84 |
| Q3 2024 | -$0.99 | -$0.55 |
| Q2 2024 | -$0.44 | +$0.14 |
NVDA has the stronger earnings trend. Trailing diluted EPS is down 130% for MRT versus NVDA up 125%.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
MRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $60.1M | +383% |
| Q4 2025 | $12.5M | +143% |
| Q3 2025 | $12.5M | +143% |
| Q2 2025 | $7.2M | +70% |
| Q1 2025 | $7.2M | +70% |
| Q4 2024 | $5.1M | -50% |
| Q3 2024 | $5.1M | +1982% |
| Q2 2024 | $4.2M | -11% |
MRT has the stronger quarterly revenue trend. Revenue is up 740% for MRT versus up 106% for NVDA.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.8% | +86 points |
| Q4 2025 | -64% | +395 points |
| Q3 2025 | -64% | +395 points |
| Q2 2025 | -88% | +129 points |
| Q1 2025 | -88% | +129 points |
| Q4 2024 | -459% | -224 points |
| Q3 2024 | -459% | -3597 points |
| Q2 2024 | -217% | -68 points |
MRT's operating margin was −1.8% last quarter, up 86 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA's revenue has grown year over year for 13 quarters in a row: $96.2B last quarter, up 106% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MRT on profitability, with a higher operating margin.
MRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.8M | +$3.2M |
| Q4 2025 | -$5M | +$2.4M |
| Q3 2025 | -$5M | +$2.4M |
| Q2 2025 | -$2.6M | +$2.6M |
| Q1 2025 | -$2.6M | +$2.6M |
| Q4 2024 | -$7.4M | +$5.8M |
| Q3 2024 | -$7.4M | -$2.6M |
| Q2 2024 | -$5.3M | -$275.7K |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with MRT at up 11%.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
MRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +4M shares |
| 1 year | +16% | +12.2M shares |
| 3 years | +149% | +51.6M shares |
MRT has 86M diluted shares, up 16% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $86,097 |
| Q3 2025 | $86,097 |
| Q2 2025 | $97,719 |
| Q1 2025 | $97,719 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over MRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
MRT Net Leverage
MRT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 57.6 | Neutral |
MRT's weekly RSI is 52 (neutral) and its Stochastic is 58 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MRT PE vs Technology Sector
MRT has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
MRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.99 | 1.5% above |
| 20 week MA | $1.91 | 5.8% above |
| 50 week MA | $2.00 | 1% above |
| 100 week MA | $2.43 | 17% below |
| 200 week MA | $3.05 | 34% below |
MRT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
MRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.75 | $9.89 | +1.4% |
| 2022 | $9.89 | $10.2 | +3.1% |
| 2023 | $10.2 | $0.65 | -94% |
| 2024 | $0.65 | $3.39 | +422% |
| 2025 | $3.39 | $2.31 | -32% |
| 2026 YTD | $2.31 | $2.02 | -13% |
MRT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.